Seattle Genetics and Agensys, an Affiliate of Astellas, Announce Initiation of Phase I Clinical Trial of ASG-5ME for Pancreatic Cancer http://finance.yahoo.com/news/Seattle-Genetics-and-Agensys-bw-3879955045.html?x=0&.v=1